The role of vasculogenic and angiogenic factors in perinatal outcomes, neonatal morbidity, and mortality in complicated monochorionic multiple pregnancies

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Relevance: Selective fetal growth restriction (sFGR) and twin-to-twin transfusion syndrome (TTTS) are the most common complications of monochorionic multiple pregnancies (10–35%) and are characterized by high perinatal mortality and a wide range of neonatal complications. The main etiological factor in the development of TTTS and sFGR is placental dysfunction, which is primarily associated with vasculogenic and angiogenic factors during monochorionic pregnancy.

Objective: This study aimed to investigate the role of vascular endothelial growth factors in perinatal outcomes, neonatal morbidity, and mortality in complicated monochorionic twin pregnancies.

Materials and methods: This was a prospective study with comparative analysis of the relationship between vasculogenic and angiogenic factors and perinatal outcomes, neonatal morbidity, and mortality in monochorionic multiple pregnancies complicated by sFGR and TTTS. The study included 84 pregnant women with monochorionic diamniotic twins and 152 newborns. An analysis of the course of pregnancy and childbirth, perinatal outcomes, and neonatal morbidity was also performed. The study also analyzed vasculogenic and angiogenic factors in the second trimester of pregnancy depending on the development of specific complications.

Results: Antenatal losses occurred in 6.45% (n=2) of patients in the TTTS group (p=0.249). Early neonatal mortality was observed in 14.3% (n=4) of the TTTS group and in 5% (n=1) of the sFGR group (p=0.272). The gestational age at delivery was significantly different in the complicated pregnancy groups (32.2–32.4 weeks) compared to the control group (36.2 weeks); (p<0.001). A study of vasculogenic and angiogenic factors in the second trimester of pregnancy showed an increase in maternal blood VEGF-C to 0.66 ng/ml and HIF-1a to 0.69 ng/ml, a decrease in VEGF-R1 to 0.73 ng/ml with neonatal mortality. In case of stillbirth, a high concentration of HIF-1a was observed (0.69 ng/ml). Changes in maternal blood concentrations of VEGF-R1 (0.787 ng/ml) and ANGPT2 (8255.91 pg/ml) were associated with the risk of fetal growth restriction. Analysis of the early neonatal period showed high respiratory, cardiovascular, and gastrointestinal morbidity in neonates from the TTTS and sFGR groups associated with prematurity and intrauterine deficits.

Conclusion: An association was found between changes in vasculogenic and angiogenic factors in the blood of pregnant women and high neonatal morbidity and mortality in complicated monochorionic twins. Specifically, the concentrations of VEGF-C and HIF-1a increased while VEGF-R1 decreased. The data obtained make it possible to predict antenatal and neonatal risks, improve perinatal outcomes, and minimize the risk of severe neonatal complications.

About the authors

Kristina A. Gladkova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: k_gladkova@oparina4.ru
ORCID iD: 0000-0001-8131-4682

MD, Ph.D, Senior Researcher at the Fetal Medicine Unit, Institute of Obstetrics, Head of the 1st Obstetric Department of Pregnancy Pathology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Russian Federation, Moscow

Zulfiya S. Khodzhaeva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: z_khodzhaeva@oparina4.ru
ORCID iD: 0000-0001-8159-3714

Dr. Med. Sci., Professor, Deputy Director of Obstetrics Institute, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Russian Federation, Moscow

Viktoriya A. Sakalo

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: v_sakalo@oparina4.ru
ORCID iD: 0000-0002-5870-4655

MD, Ph.D, Junior Researcher at the Department of Pregnancy Pathology, Institute of Obstetrics, Obstetrician-Gynecologist at the 1st Obstetric Department of Pregnancy Pathology, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Russian Federation, Moscow

Ekaterina R. Frolova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: kattirella@gmail.com
ORCID iD: 0000-0003-2817-3504

PhD Student at the High-Risk Pregnancy Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Russian Federation, Moscow

Marika N. Shakaya

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: k_gladkova@oparina4.ru
ORCID iD: 0000-0002-3838-3321

Neonatologist the A.G. Antonov Neonatal Intensive Care Unit, Institute of Neonatology and Pediatrics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Teaching Assistant at the N.F. Filatov Department of Neonatology, Faculty of Pediatrics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

Russian Federation, Moscow; Moscow

Аnna R. Kirtbaya

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: a_kirtbaya@oparina4.ru
ORCID iD: 0000-0002-7628-8157

Dr. Med. Sci., Clinical Care Supervisor at the A.G. Antonov Neonatal Intensive Care Unit, Institute of Neonatology and Pediatrics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Professor at the N.F. Filatov Department of Neonatology, Faculty of Pediatrics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

Bouvet Island, Moscow; Moscow

References

  1. Cheong-See F., Schuit E., Arroyo-Manzano D., Khalil A., Barrett J., Joseph K.S. et al. Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis. BMJ. 2016; 354: i4353. https://dx.doi.org/10.1136/bmj.i4353.
  2. Mackie F.L., Morris R.K., Kilby M.D. The prediction, diagnosis and management of complications in monochorionic twin pregnancies: the OMMIT (Optimal Management of Monochorionic Twins) study. BMC Pregnancy Childbirth. 2017;17(1):153. https://dx.doi.org/10.1186/s12884-017-1335-3.
  3. D’Antonio F., Benlioglu C., Sileo F.G., Thilaganathan B., Papageorghiou A., Bhide A., Khalil A. Perinatal outcomes of twin pregnancies affected by early twin-twin transfusion syndrome: A systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2020; 99(9): 1121-34. https://dx.doi.org/10.1111/ aogs.13840.
  4. Wang X., Li L., Yuan P., Zhao Y., Wei Y. Placental characteristics in different types of selective fetal growth restriction in monochorionic diamniotic twins. Acta Obstet. Gynecol. Scand. 2021;100(9):1688-93. https://dx.doi.org/10.1111/aogs.14204.
  5. Valsky D.V., Eixarch E., Martinez J.M., Crispi F., Gratacós E. Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas. Semin. Fetal. Neonatal. Med. 2010;15(6):342-8. https://dx.doi.org/10.1016/j.siny.2010.07.002.
  6. Wu J., He Z., Gao Y., Zhang G., Huang X., Fang Q. Placental NFE2L2 is discordantly activated in monochorionic twins with selective intrauterine growth restriction and possibly regulated by hypoxia. Free Radic. Res. 2017;51(4):351-9. https://dx.doi.org/10.1080/10715762.2017.1315113.
  7. Ivanov D., Mazzoccoli G., Anderson G., Linkova N., Dyatlova A., Mironova E. et al. Melatonin, its beneficial effects on embryogenesis from mitigating oxidative stress to regulating gene expression. Int. J. Mol. Sci. 2021;22(11):5885. https://dx.doi.org/10.3390/ijms22115885.
  8. Demir R., Kayisli U., Seval Y., Celik-Ozenci C., Korgun E., Demir-Weusten A., Huppertz B. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004;25(6):560-72. https://dx.doi.org/10.1016/ j.placenta.2003.11.011.
  9. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol. 1997;104(2):223-8. https://dx.doi.org/10.1111/j.1471-0528.1997.tb11050.x.
  10. Kaufmann P., Mayhew T.M., Charnock-Jones D.S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004;25(2-3):114-26. https://dx.doi.org/10.1016/j.placenta.2003.10.009.
  11. Tammela T., Zarkada G., Nurmi H., Jakobsson L., Heinolainen K., Tvorogov D. et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 2011;13(10):1202-13. https://dx.doi.org/10.1038/ncb2331.
  12. He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., Charnock-Jones D.S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol. Endocrinol. 1999;13(4):537-45. https://dx.doi.org/10.1210/mend.13.4.0265.
  13. Wang X.-H., Xu S., Zhou X.-Y., Zhao R., Lin Y., Cao J. et al. Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk. Nat. Commun. 2021;12(1):3428. https://dx.doi.org/10.1038/ s41467-021-23827-0.
  14. Gunatillake T., Yong H.E., Dunk C.E., Keogh R.J., Borg A.J., Cartwright J.E. et al. Homeobox gene TGIF-1 is increased in placental endothelial cells of human fetal growth restriction. Reproduction. 2016;152(5):457-65. https://dx.doi.org/10.1530/REP-16-0068.
  15. Taylor M. Validation of the Quintero staging system for twin-twin transfusion syndrome. Obstet Gynecol. 2002;100(6):1257-65. https://dx.doi.org/10.1016/S0029-7844(02)02392-X.
  16. Basavaraja R., Drum J.N., Sapuleni J., Bibi L., Friedlander G., Kumar S. et al. Downregulated luteolytic pathways in the transcriptome of early pregnancy bovine corpus luteum are mimicked by interferon-tau in vitro. BMC Genomics. 2021;22(1):452. https://dx.doi.org/10.1186/s12864-021-07747-3.
  17. Mert I., Sargın Oruc A., Yuksel S., Cakar E.S., Buyukkagnıcı U., Karaer A., Danısman N. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J. Obstet. Gynaecol. Res. 2012;38(4):658-64. https://dx.doi.org/ 10.1111/j.1447-0756.2011.01771.x.
  18. Ge L., Yu D., Su R., Cao Y. [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018;32(3):264-9. https://dx.doi.org/10.7507/ 1002-1892.201710104.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. ROC curve of the relationship between the probability of giving birth to newborns with low body weight and the level of VEGF-R1 in the blood plasma of a pregnant woman

Download (91KB)
Indexing metadata
3. Fig. 2. ROC curve of the relationship between the probability of giving birth to newborns with low body weight and the level of ANGPT2 in the blood plasma of a pregnant woman

Download (93KB)
Indexing metadata

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».